Stay updated on Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.

Latest updates to the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry, Revision: v3.6.5, was added to the history, replacing the previous Revision: v3.6.4.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated in the history from v3.6.3 to v3.6.4, reflecting a new site release in the record history. It does not modify any study information.SummaryDifference0.1%

- Check44 days agoChange DetectedA new page revision entry for v3.6.3 is added to the study record history, replacing the previous v3.6.0, indicating a page-wide update rather than changes to study content.SummaryDifference0.1%

- Check58 days agoChange DetectedRecruitment status updated to indicate no longer looking for participants. The revision metadata was updated to version 3.6.0, replacing the previous 3.5.5.SummaryDifference0.4%

- Check65 days agoChange DetectedA new revision, v3.5.5, was added to the record history, replacing the previous v3.5.4. This reflects an update to the page’s revision-tracking version within ClinicalTrials.gov.SummaryDifference0.1%

- Check87 days agoChange DetectedA new revision entry, Revision: v3.5.4, was added to the Record History for the study page. The previous revision, v3.5.3, is no longer current in the visible history.SummaryDifference0.1%

Stay in the know with updates to Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.